Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19

  • STATUS
    Recruiting
  • participants needed
    100
  • sponsor
    Sheba Medical Center
Updated on 19 February 2024
covid-19
SARS
ivermectin
viral shedding
acute respiratory syndrome (sars)

Summary

Ivermectin which is an FDA-approved broad spectrum anti-parasitic agent, has also anti-viral activity. In vitro study have shown its activity against SARS-CoV-2, however its clinical effect on patients with COVID-19 never been tested.

In this RCT we would like to evaluate the effect of Ivermectin on reduction of viral shedding among mild to moderate COVID-19 patients, and in shortening the symptom resolution time.

Details
Condition Covid 19
Age 18-80 years
Treatment Ivermectin Oral Product
Clinical Study IdentifierNCT04429711
SponsorSheba Medical Center
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Participants eligible for inclusion will include non-pregnant adult (>18 years
old) with molecular confirmation of COVID-19. [Participants will be eligible
in a period of no longer than 72 hours after exposure]

Exclusion Criteria

Severe infection ( defined as need for invasive or non-invasive ventilator support, ECMO or shock requiring vasopressor support)
Weight below 40Kg or above 100Kg
Unable to take oral medication
Known allergy to the drugs
Pregnancy or breast feeding
Participating in another RCT for treatment of COVID-19
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.